Systematic evidence analysis for the transition from relapsing to secondary progressive Multiple Sclerosis in adults

被引：0
|
作者：
Badgujar, L. [1 ]
Khurana, V. [1 ]
Malepati, A. [1 ]
Meier, D. Piani [2 ]
Adlard, N. [2 ]
机构：
[1] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
[2] Novartis Pharma AG, Basel, Switzerland
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1208
引用
收藏
页码：471 / 472
页数：2
相关论文
共 50 条
  • [21] Mitoxantrone treatment in patients with relapsing remitting and secondary progressive multiple sclerosis
    Simu, M.
    Chirileanu, R. D.
    Reisz, D.
    Murariu, A.
    Lata, I.
    Suici, M.
    Bednar, M.
    Barsasteanu, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 288 - 288
  • [22] Interferon β for secondary progressive multiple sclerosis: a systematic review
    La Mantia, Loredana
    Vacchi, Laura
    Rovaris, Marco
    Di Pietrantonj, Carlo
    Ebers, George
    Fredrikson, Sten
    Filippini, Graziella
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (04): : 420 - 426
  • [23] Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis
    Jongen, PJH
    Lamers, KJB
    Doesburg, WH
    Lemmens, WAJG
    Hommes, OR
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (04): : 446 - 451
  • [24] NEDA as a predictor of conversion to secondary progressive multiple sclerosis in patients with relapsing-remitting multiple sclerosis
    Kappos, L.
    Stefano, N. D.
    Sormani, M. P.
    Giovannoni, G.
    Haring, D.
    Tomic, D.
    Meier, D. Piani
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 638 - 639
  • [25] Assessment of clinical definitions of conversion of relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis
    Diaz-Cruz, Camilo
    Healy, Brian
    Chua, Alicia
    Bhattacharyya, Shamik
    Kimbrough, Dorlan
    Severson, Christopher
    Stankiewicz, James
    Sattarnezhad, Neda
    Glanz, Bonnie
    Weiner, Howard
    Chitnis, Tanuja
    NEUROLOGY, 2017, 88
  • [26] A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis
    Dickens, Alex M.
    Larkin, James R.
    Griffin, Julian L.
    Cavey, Ana
    Matthews, Lucy
    Turner, Martin R.
    Wilcock, Gordon K.
    Davis, Benjamin G.
    Claridge, Timothy D. W.
    Palace, Jacqueline
    Anthony, Daniel C.
    Sibson, Nicola R.
    NEUROLOGY, 2014, 83 (17) : 1492 - 1499
  • [27] A TYPE 2 BIOMARKER SEPARATES RELAPSING-REMITTING FROM SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
    Gilbert, Gordon J.
    NEUROLOGY, 2015, 84 (21) : 2201 - 2201
  • [28] A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis
    Gaudino, EA
    Chiaravalloti, ND
    DeLuca, J
    Diamond, BJ
    NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY, 2001, 14 (01): : 32 - 44
  • [29] Pattern of cognitive impairment in relapsing-remitting, secondary progressive and primary progressive multiple sclerosis
    Batocchi, AR
    Tomasello, C
    Nociti, V
    Mirabella, M
    Marra, C
    MULTIPLE SCLEROSIS, 2005, 11 : S70 - S70
  • [30] Differential patterns of memory performance in relapsing, remitting and secondary progressive multiple sclerosis
    Drake, Marina A.
    Carra, Adriana
    Allegri, Ricardo F.
    Luetic, Geraldine
    NEUROLOGY INDIA, 2006, 54 (04) : 370 - 376
12345